We're delighted to announce that the 8th edition of the Immunorad conference will take place in New York, October 3-5, 2024. Stay tuned for more details on the program, keynote speakers and registration details. In the meantime, please mark these dates in your calendar and consider planning to attend this unforgettable event.
The clinical management of cancer is being revolutionized by agents that activate the immune system against the tumor. Nevertheless, many of these therapies benefit only to a minority of patients. In this context, radiotherapy is holding great promises as a means to complement immunotherapy in the management of malignant disorders. In particular, radiotherapy can generate an “in situ vaccination” effect that is at the foundation of optimal immune responses against cancer cells. Thus, the clinical potential of combining immunotherapy with radiotherapy is extraordinary.
This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.
Follow conference news and exchange comments with subscribers, interact and share your ideas.